[Virtual consultations in paediatrics]

Ole Haubjerg Nielsen1, Grete Katrine Teilmann

  • 1ole.haubjerg.nielsen@regionh.dk.

Ugeskrift for Laeger
|June 25, 2021
PubMed

Insights

Telemedicine in pediatrics rapidly expanded during COVID-19, showing high parental satisfaction and comparable outcomes to in-person visits. However, technological barriers and a lack of child/adolescent perspectives highlight the need for guidelines and education.

Area of Science:

  • Pediatric healthcare
  • Digital health technologies
  • Public health during pandemics

Background:

  • The COVID-19 pandemic accelerated the global adoption of telemedicine and virtual consultations in pediatrics.
  • Existing research indicates significant parental satisfaction with telemedicine services.
  • Technological challenges represent a primary obstacle to widespread telemedicine implementation.

Purpose of the Study:

  • To review the current state of telemedicine in pediatrics.
  • To identify barriers and facilitators for its implementation.
  • To highlight areas for future development, including guidelines and education.

Main Methods:

  • Literature review of studies on pediatric telemedicine.
  • Analysis of research focusing on parental satisfaction, technological barriers, clinical outcomes, and stakeholder perspectives.
  • Synthesis of findings to identify gaps in current knowledge and practice.

Main Results:

  • Telemedicine has demonstrated comparable clinical outcomes to in-person visits in some studies.
  • Parental perspectives are largely positive, but child and adolescent viewpoints are underrepresented.
  • Technological infrastructure and accessibility remain significant implementation barriers.

Conclusions:

  • Further research is needed to understand the experiences of children and adolescents with telemedicine.
  • Development of specific guidelines and educational programs for pediatric telemedicine is crucial.
  • Addressing technological barriers is essential for optimizing virtual care in pediatrics.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
48
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
69
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.0K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.9K